Skip to main content
. 2023 Jul 21;15(7):1998. doi: 10.3390/pharmaceutics15071998

Figure 8.

Figure 8

XTT assay results summary of A549 cells treated with DOX, LAP-mPEG/DOX, and LAP-cPEG/DOX at DOX concentrations of 0.75, 1, and 1.25 µM The viability of the cells treated with LAP-cPEG/DOX was significantly decreased compared to those treated with LAP-mPEG/DOX (* p < 0.05; ** p < 0.01).